rs73637412
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_054021.2(GPR101):āc.924G>Cā(p.Glu308Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00476 in 1,209,166 control chromosomes in the GnomAD database, including 15 homozygotes. There are 1,903 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_054021.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR101 | NM_054021.2 | c.924G>C | p.Glu308Asp | missense_variant | 2/2 | ENST00000651716.2 | NP_473362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR101 | ENST00000651716.2 | c.924G>C | p.Glu308Asp | missense_variant | 2/2 | NM_054021.2 | ENSP00000498972 | P1 | ||
ENST00000693626.2 | n.394-29774C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00344 AC: 382AN: 110993Hom.: 1 Cov.: 22 AF XY: 0.00274 AC XY: 91AN XY: 33195
GnomAD3 exomes AF: 0.00353 AC: 647AN: 183283Hom.: 1 AF XY: 0.00365 AC XY: 247AN XY: 67727
GnomAD4 exome AF: 0.00489 AC: 5368AN: 1098119Hom.: 14 Cov.: 32 AF XY: 0.00499 AC XY: 1812AN XY: 363479
GnomAD4 genome AF: 0.00344 AC: 382AN: 111047Hom.: 1 Cov.: 22 AF XY: 0.00274 AC XY: 91AN XY: 33259
ClinVar
Submissions by phenotype
Pituitary adenoma, growth hormone-secreting, 2 Pathogenic:1Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 26, 2015 | - - |
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
GPR101-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 03, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at